Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma-Reference-Cited by-同舟云学术

Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma

Published:2020-09 Issue: Volume:196 Page:106006
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Seyve Antoine^ORCID,Lozano-Sanchez Fernando,Thomas Alice,Mathon Bertrand^ORCID,Tran Suzanne,Mokhtari Karima,Giry Marine,Marie Yannick,Capelle Laurent,Peyre Matthieu,Carpentier Alexandre,Feuvret Loic,Sanson Marc,Hoang-Xuan Khê,Honnorat Jérome,Delattre Jean-Yves,Ducray François,Idbaih Ahmed

Funder

Institut National Du Cancer

Publisher

Elsevier BV

Subject

Clinical Neurology,General Medicine,Surgery

Reference39 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016;Ostrom;Neuro-Oncol.,2019

2. The epidemiology of glioma in adults: a “state of the science” review;Ostrom;Neuro-Oncol.,2014

3. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma;Weller;Lancet Oncol.,2014

4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol.,2009

5. Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010;Nava;Neuro-Oncol.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Factors for Progression-free Survival and Overall Survival After Recurrence of Glioblastoma;Anticancer Research;2024-06-26

2. Optimizing Recurrent Glioblastoma Salvage Treatment: A Multicenter Study Integrating Genetic Biomarkers From the Korean Radiation Oncology Group (21-02);Neurosurgery;2024-03-21

3. Can Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Outcomes of Patients With Recurrent Glioblastoma?;In Vivo;2024

4. Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence;Medicine;2023-12-01

5. Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?;Cancers;2022-11-09